SELLAS Life Sciences Group, Inc. (SLS)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
NasdaqCM · Price as of · Delayed Quote
- Profitability0/20
Losing money: $-35.8M net income over the last four reported quarters.
- Insider buying vs selling15/20
The last 1 Form 4s show no open-market buys or sells (grants and option exercises don't count either way). Neutral. Separately, 3 new 5%+ stake disclosures (13D/13G) hit in the last 6 months, which is big-money accumulation.
- Dilution and offerings1/15
Share count up 43.1% in a year and 1 offering-related filing. Heavy dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.
- Analysts2
- Implied upside+62.8%
- Target range$30.00 to $35.00
SLS closed at $20.16 on Nov 17, up 92.2% since Oct 19. Chart read: price above both the 50-day and 200-day moving averages; the 50-day is above the 200-day (uptrend structure); trading at 100% of the 52-week range ($1.39 to $20.16).
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | November 17, 2026 | FORM 8-K |
| 8-K | November 12, 2026 | 8-K |
| 10-Q | November 12, 2026 | 10-Q |
| SCHEDULE 13G | November 10, 2026 | View on EDGAR |
| SCHEDULE 13G/A | October 27, 2026 | View on EDGAR |
| 8-K | August 11, 2026 | 8-K |
| 10-Q | August 11, 2026 | 10-Q |
| SCHEDULE 13G | August 7, 2026 | View on EDGAR |
SELLAS Life Sciences news
Frequently asked questions
What do analysts expect for SLS?
2 analysts cover SELLAS Life Sciences Group, Inc. (SLS). The consensus rating is Strong buy. The average price target is $32.50, in a range of $30.00 to $35.00.
Are insiders buying or selling SLS?
We have no qualifying Form 4 insider purchases or sales on record for SELLAS Life Sciences Group, Inc. (SLS). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see SLS SEC filings?
Recent filings are listed on this page, newest first. The latest is an 8-K filed November 17, 2026.
